Web8 Apr 2024 · Medicine is constantly changing and evolving, and rheumatology in particular is a specialty in which diseases that were unknown a few decades ago can now be correctly identified and successfully treated with targeted therapies. Furthermore, exactly these advances regularly confront us with the challenging decision of whether similar diseases … WebCoronavirus SARS-CoV-2 is currently causing a pandemic of COVID-19, with more than 3 million confirmed cases around the globe identified as of June 2024. During these extraordinary times, caring for patients with COVID-19 and underlying COPD poses particular challenges. Certain treatments relevant to treating patients with COPD, such …
Recommendations following a modified UK-Delphi consensus …
WebJules M Janssen Daalen ,1,2,3 Anouk den Ambtman ,2,4 Mark Van Houdenhoven,2,4 Bart J F van den Bemt3,5,6 To cite: Janssen Daalen JM, den Ambtman A, Van Houdenhoven M, et al. Determinants of drug prices: a systematic review of comparison studies. BMJ Open 2024;0:e046917. doi:10.1136/ bmjopen-2024-046917 Prepublication history and WebBMJ Open Resp Res: first published as 10.1136/bmjresp-2024-001057 on 28 September 2024. Downloaded from . 2 acsonfiD etal Open esp es 20248e001057 doi101136bmjresp2024001057 Open access Despite the introduction of specialist asthma services in many parts of the UK and the increased availability of scrum waterfall
A randomised controlled trial on the efficacy of advance ... - BMJ …
Web20 Jul 2024 · Introduction: Myasthenia gravis (MG) is a rare, chronic, autoimmune disease, mediated by immunoglobulin G antibodies, which causes debilitating muscle weakness. As with most rare diseases, there is little patient-reported data with which to understand and address patient needs. This study explores the impact of MG in the real world from the … Web2 Mar 2024 · The single dose covid-19 vaccine made by Janssen, the pharmaceutical arm of Johnson & Johnson, has now been given emergency use authorisation by the US … WebDick Janssen1 To cite: van Ginkel C, Baars C, Heesakkers J, et al. Study protocol of a multicentre double-blind RCT, comparing a traditional RCT with an ggregaa ted N- of- 1 trial: GAG therapy Efficacy Trial Solution for Bladder pain syndrome/Interstitial cystitis (GETSBI study). BMJ Open 2024;13:e068546. doi:10.1136/ bmjopen-2024-068546 scrum was developed in the early